CLRB icon

Cellectar Biosciences

17 hedge funds and large institutions have $3.01M invested in Cellectar Biosciences in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
3
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BC
1
Boxer Capital
California
$1.84M 920,000
TCM
2
Tang Capital Management
California
$471K 235,701 -444,299 -65%
Renaissance Technologies
3
Renaissance Technologies
New York
$354K 176,902 +53,854 +44%
SFM
4
Sphera Funds Management
Israel
$175K 87,500
Morgan Stanley
5
Morgan Stanley
New York
$64K 32,229 -3,010 -9%
Vanguard Group
6
Vanguard Group
Pennsylvania
$34K 16,755
JPMorgan Chase & Co
7
JPMorgan Chase & Co
New York
$21K 10,505 +10,505 New
PAG
8
Private Advisor Group
New Jersey
$20K 13,400
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$18K 9,000 +5,000 +125%
US Bancorp
10
US Bancorp
Minnesota
$6K 2,859
Victory Capital Management
11
Victory Capital Management
Texas
$3K 1,291 +1,291 New
KFS
12
Kelly Financial Services
Massachusetts
$54 27
AIC
13
AWM Investment Company
New York
-106,600 Closed
CH
14
CVI Holdings
Delaware
-106,026 Closed
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
-10,300 Closed
SIM
16
Sonora Investment Management
Arizona
-500 Closed
AG
17
Advisor Group
Arizona
$0 5
AWM
18
AllSquare Wealth Management
New York
$0 188
BlackRock
19
BlackRock
New York
$0 59
CFGS
20
Concourse Financial Group Securities
Alabama
IA
21
IFP Advisors
Florida
$0 5 +5 New
Bank of America
22
Bank of America
North Carolina
$0 31 +26 +520%